Carl Perez

FDA investigator

Appears on 7 documents from 2022 to 2025, most often at sites in California. Most often cites written procedures; deviations (21 CFR 211.100).

7
Documents on file
3.3
Observations per 483
2022
First seen
2025
Most recent

What they cite most

From 23 observations

Activity by year

2022: 1, 2023: 2, 2024: 2, 2025: 2

Where

California 1 · Maryland 1 · Massachusetts 1 · New Jersey 1 · Pennsylvania 1 · United Kingdom 1

Often inspects with

Jie He· Kevin Matthews· Donald Ertel

Is Carl Perez coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Clongen Laboratories, LLCJun 17, 2025 · Gaithersburg, Maryland
483 Capricor, Inc.May 30, 2025 · California
483 FDA Form 483 Janssen, Raritan, NJ Oct 2024Nov 1, 2024 · Raritan, New Jersey
483 FDA Form 483 Lonza Netherlands BV, Geleen, Netherlands, July 2024Jul 12, 2024
483 Roslin Cell Therapies LimitedAug 4, 2023 · Edinburgh, United Kingdom
483 Berkshire Sterile Manufacturing (BSM)Jan 20, 2023 · Lee, Massachusetts
483 Krystal Biotech, Inc.Nov 16, 2022 · Pittsburgh, Pennsylvania

About this profile

What does Carl Perez inspect?

Carl Perez appears on 7 documents on file covering 7 sites, most often in California.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Carl Perez is dated Jun 17, 2025.

FDA Investigator Carl Perez: 483s & Inspections · FDA Intel